MedTrace Logo

Safety and Efficacy of a Glaucoma Drug Delivery System

NCT00824720 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2015-03-06

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the ocular safety and efficacy of a glaucoma drug delivery system in open-angle glaucoma or ocular hypertension.

Conditions

Interventions

DRUG

High Dose Device

inserted for 14 days

DRUG

Low Dose Device

inserted for 14 days

DEVICE

Placebo Device

inserted for 14 days

Sponsors & Collaborators

  • Vistakon Pharmaceuticals

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2009-04-30
Completion
2009-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00824720 on ClinicalTrials.gov